WHO Mental Health Gap Action Program (mhGAP) for Improving Child Mental and Behavioral Disorder Service Quality in China
NCT ID: NCT06702410
Last Updated: 2025-05-16
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
375 participants
INTERVENTIONAL
2024-11-20
2026-02-20
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
* Does the adapted mhGAP-IG reduce the symptom severity among children with CMBDs between two and sis years old?
* Does the adapted mhGAP-IG reduce psychological distress among caregivers of children with CMBDs?
* Does the adapted mhGAP-IG improve mental and behavioral health serivces capacity among kindergarten teachers in China?
* How is the feasibility, acceptablity, and what are barriers and facilitators of implementation?
Researchers will compare the adapted mhGAP-IG to child healthcare as usual to see if the adapted mhGAP-IG can improve quality of child mental and behavioral disorders services in China.
Participants (kindergarten teachers) will:
* Complete questionnaires and scales at baseline and at 3-, 6-, 9- and 12- months of intervention;
* Receive mhGAP-based trainings;
* Deliver long-term child mental and behavioral disorders services (including screenings, referals, follow-up, and physcosocial interventions) to children with CMBDs.
Participants (children/caregivers) will:
* Complete questionnaires and scales at baseline and at 3-, 6- and 12- months of intervention.
* Accept long-term CMBDs management (including screenings, referals, follow-up management, and physcosocial interventions) from mhGAP-trained kindergarten teachers.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Effectiveness of Mental Wellness Youth Hubs in Hong Kong
NCT06868303
Evaluating the Clinical Cost-effectiveness of Two Primary Mental Health Service Frameworks in Yogyakarta, Indonesia
NCT02700490
WHO QualityRights E-training in Ghana
NCT04728243
A Randomized Controlled Trial of the Efficacy of the Lighthouse Parenting Programme in Addressing Parenting Difficulties in China
NCT06858059
Multimodal Psychotherapy Training for Chinese Medical Students
NCT06258460
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Overall goal: Using a hybrid Type I trial design, To evaluate the effectiveness and implementation of the adapted mhGAP-IG at kindergartens in Guangdong province, China.
Methods: The effectiveness and implementation of the adapted mhGAP-IG will be tested in a stepped-wedge cluster randomized controlled trial. The trail will recruit 20 kindergartens and 375 children in Zhongshan City. Kindergartens will be randomly and subsequently enrolled at regular intervals (steps). At each step, kindergarten teachers will receive the mhGAP-IG training and then cross over from the control condition (providing child mental and behavioral disorders services as usual) to the intervention condition (providing child mental and behavioral disorders services under the adapted mhGAP-IG).
Outcome measures:Symptom severity of CMBDs measured by the Strengths and Difficulties Questionnaire is set as the primary outcome. Implementation measurements will cover the five domains of the Reach, Effectiveness, Adoption, Implementation, Maintenance (RE-AIM) framework.
Implications: This project will provide additional evidence of the effectiveness of the mhGAP-IG in improving quality of CMBDs services. The lessons learned from this project can aid in scaling the training to other regions of China and LMICs.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SEQUENTIAL
HEALTH_SERVICES_RESEARCH
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
the adapted mhGAP-IG
mhGAP-IG-based CMBDs mental health services (including screening, management and follow-up) delivered by trained kindergarten teachers
mental health gap action program intervention guide (mhGAP-IG)
The mhGAP-IG is an evidence-based intervention developed by WHO. It was designed for non-specialists to scale up high quality mental health services. Although more than 90 countries worldwide have implemented mhGAP-IG, this study is the first to evaluated if it works for scaling up CMBDs services in China. Investigators have cultrually adapted the mhGAP-IG according Chinese context.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
mental health gap action program intervention guide (mhGAP-IG)
The mhGAP-IG is an evidence-based intervention developed by WHO. It was designed for non-specialists to scale up high quality mental health services. Although more than 90 countries worldwide have implemented mhGAP-IG, this study is the first to evaluated if it works for scaling up CMBDs services in China. Investigators have cultrually adapted the mhGAP-IG according Chinese context.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Screened positive by the mhGAP-IG screening tool;
* Will stay in Zhongshan City for the next one year.
* Have one or more years of work experience in the selected kindergartens
* Be available to participate in the mhGAP training.
Exclusion Criteria
* Currently or in the past six months received CMBDs services provided by specialized mental health workers;
* Deafness or blindness in the child or caregivers;
* Not available or unwilling to participate in the trial.
2. Eligibility criteria for kindergarten teachers
* Have received the mhGAP training before;
* Have arrangements requiring long-term leave from work in the next one year;
* Unwilling to participate in the trial.
2 Years
6 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Sun Yat-sen University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Wen Chen
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Wen Chen, PhD
Role: PRINCIPAL_INVESTIGATOR
Medical statistics, School of public health, Sun Yat-sen University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Zhongshan Zhengfa Kindergarten
Zhongshan, Guangdong, China
Zhongshan Xiaolan Huasheng Kindergarten
Zhongshan, Guangdong, China
Zhongshan Dongfeng Deshan Kindergarten
Zhongshan, Guangdong, China
Zhongshan Huangpu Boya Oriental Pearl Kindergarten
Zhongshan, Guangdong, China
First Kindergarten in Zhongshan Torch High-Tech Industrial Development Zone
Zhongshan, Guangdong, China
Third Kindergarten in Zhongshan Torch High-Tech Industrial Development Zone
Zhongshan, Guangdong, China
Xiao Yin Kindergarten in Zhongshan Torch High-Tech Industrial Development Zone
Zhongshan, Guangdong, China
Zhangjiabian Kindergarten in Zhongshan Torch High-Tech Industrial Development Zone
Zhongshan, Guangdong, China
Shaxi Xin Shimen Kindergarten in Zhongshan City.
Zhongshan, Guangdong, China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Xue-zhi Liang
Role: primary
Ming-lu Yuan
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
20-389
Identifier Type: OTHER_GRANT
Identifier Source: secondary_id
2022B1515020094
Identifier Type: OTHER_GRANT
Identifier Source: secondary_id
2020-089
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.